Biotech Values

[makingmoneynow]

ICOTF gets a new coverage by Zach small Cap resreach

Zachs small cap research just issued coverage on ICo Therapeutics with an initial target of 90 cents, which is on the down side. Zach places iCo valuation at 100 to 150 million dollar based on a 50% success rate for 007. This translates to a range between 90 and a 1.30 assuming all warrants are exercised (see link below).

This further shows how undervalued iCo is currently and the big win will be if 007 primary efficacy data comes positive, which would lift the 50% odd and make the Company worth anywhere between 1.80 and 2.60.

So between now and data, we have more than a double on the table to be taken. That is a potential 100% to 150% within only 5 to 9 weeks away!!

I believe yesterday's volume of 2.2m along with the price appreciation of 13% is just the start of a major run towards data.

Good luck with your investments,
MMN

http://scr.zacks.com/files/doc_coverage/Biotech%20-%20Jason%20Napodano/ICOTF/Feb
ruary%2025%202014_ICOTF_Napodano.pdf

https://twitter.com/makingmoneynow1